Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Added cell line term for #2166 #2233

Merged
merged 1 commit into from
Jun 7, 2024
Merged
Changes from all commits
Commits
File filter

Filter by extension

Filter by extension

Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
9 changes: 9 additions & 0 deletions src/ontology/efo-edit.owl
Original file line number Diff line number Diff line change
Expand Up @@ -16997,6 +16997,7 @@ Declaration(Class(efo:EFO_0022610))
Declaration(Class(efo:EFO_0022611))
Declaration(Class(efo:EFO_0022612))
Declaration(Class(efo:EFO_0022613))
Declaration(Class(efo:EFO_0022614))
Declaration(Class(efo:EFO_0030000))
Declaration(Class(efo:EFO_0030001))
Declaration(Class(efo:EFO_0030002))
Expand Down Expand Up @@ -204479,6 +204480,14 @@ AnnotationAssertion(oboInOwl:hasDbXref efo:EFO_0022613 "SNOMEDCT:50846009")
AnnotationAssertion(rdfs:label efo:EFO_0022613 "gangrenous appendicits"@en)
SubClassOf(efo:EFO_0022613 efo:EFO_0007149)

# Class: efo:EFO_0022614 (HCASMC-hTERT)

AnnotationAssertion(Annotation(efo:definition_citation "PMID:37017084") obo:IAO_0000115 efo:EFO_0022614 "An immortalized human coronary artery smooth muscle cell derived cell line.")
AnnotationAssertion(dc:creator efo:EFO_0022614 "Zoe May Pendlington")
AnnotationAssertion(dc:date efo:EFO_0022614 "2024-06-07T11:00:55Z"^^xsd:dateTime)
AnnotationAssertion(rdfs:label efo:EFO_0022614 "HCASMC-hTERT"@en)
SubClassOf(efo:EFO_0022614 efo:EFO_0005735)

# Class: efo:EFO_0030000 (STARmap)

AnnotationAssertion(Annotation(oboInOwl:hasDbXref "PMID:29930089") Annotation(oboInOwl:hasDbXref "https://orcid.org/0000-0002-3090-9894") obo:IAO_0000115 efo:EFO_0030000 "STARmap is an image-based technology for 3D intact-tissue RNA sequencing, which integrates hydrogel-tissue chemistry, targeted signal amplification, and in situ sequencing.")
Expand Down
Loading